Literature DB >> 25066177

Obesity, inflammation, and the gut microbiota.

Amanda J Cox1, Nicholas P West2, Allan W Cripps2.   

Abstract

As the prevalence of obesity and associated disease continues to rise and concerns for the spiralling economic and social costs also escalate, innovative management strategies beyond primary prevention and traditional lifestyle interventions are urgently needed. The biological basis of disease is one avenue for further exploration in this context. Several key inflammatory markers have been consistently associated with both obesity and risk of adverse outcomes in obesity-associated diseases, which suggests that a persistent, low-grade, inflammatory response is a potentially modifiable risk factor. In this Review, we provide evidence supporting perturbation of the intestinal microbiota and changes in intestinal permeability as potential triggers of inflammation in obesity. Further characterisation of the mechanisms underpinning the triggers of such inflammatory responses in overweight and obese individuals could offer unique opportunities for intervention strategies to help ameliorate the risk of obesity-associated disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25066177     DOI: 10.1016/S2213-8587(14)70134-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  194 in total

Review 1.  Clinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes.

Authors:  Kadri Haller-Kikkatalo; Raivo Uibo
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 3.  Connection between gut microbiome and the development of obesity.

Authors:  Cuiting Zhi; Jingqing Huang; Jin Wang; Hua Cao; Yan Bai; Jiao Guo; Zhengquan Su
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-31       Impact factor: 3.267

Review 4.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

Review 5.  Time-Restricted Eating, Intermittent Fasting, and Fasting-Mimicking Diets in Weight Loss.

Authors:  Maura Fanti; Amrendra Mishra; Valter D Longo; Sebastian Brandhorst
Journal:  Curr Obes Rep       Date:  2021-01-29

6.  Neonatal environment exerts a sustained influence on the development of the intestinal microbiota and metabolic phenotype.

Authors:  Claire A Merrifield; Marie C Lewis; Bernard Berger; Olivier Cloarec; Silke S Heinzmann; Florence Charton; Lutz Krause; Nadine S Levin; Swantje Duncker; Annick Mercenier; Elaine Holmes; Mick Bailey; Jeremy K Nicholson
Journal:  ISME J       Date:  2015-06-12       Impact factor: 10.302

Review 7.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

8.  Evaluation of Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples.

Authors:  Nicole Fischer; Daniela Indenbirken; Thomas Meyer; Marc Lütgehetmann; Heinrich Lellek; Michael Spohn; Martin Aepfelbacher; Malik Alawi; Adam Grundhoff
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

9.  Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Authors:  Zohreh Karbaschian; Zeinab Mokhtari; Abdolreza Pazouki; Ali Kabir; Mahdi Hedayati; Somayeh Soleymanzadeh Moghadam; Parvin Mirmiran; Azita Hekmatdoost
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

10.  Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection?

Authors:  Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Juan P Kusanovic; Nikolina Docheva; Alicia Martinez-Varea; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.